High on the wish list for PWDs is cheaper insulin. Costing over $100 a bottle (without insurance), this life-saving liquid can drain your bank account faster than your blood sugar goes up after a bowl of cereal. With so many over-the-counter and prescription drugs going generic and finally saving patients hundreds of dollars, naturally we’re wondering, “When on earth are we gonna get generic insulin?”
Sadly, probably not anytime soon.
Bio-What?
In fact, there really…
Read more »
By
WilD on
February 11, 2012
Diabetes isn’t very loving, but here at the ‘Mine, we’re here to support you! Welcome to another edition of our weekly advice column, Ask D’Mine, hosted by veteran type 1, diabetes author and community educator Wil Dubois.
Mysteries are all around us in the world of diabetes, and today Wil tackles a couple involving Lantus.
{Need help navigating life with diabetes? Email us at AskDMine@diabetesmine.com}
Francisco from New Jersey, type 2, writes: I took…
Read more »
It’s not too often we have a new insulin making its way on the scene, so we were excited to hear that Novo Nordisk filed two applications with the FDA for a new “ultra long acting” insulin called Degludec, and another for something called DegludecPlus, a combination of degludec and insulin aspart (Novolog), which would be available in an insulin pen in a fixed 70% degludec/30% Novolog ratio. The company is hoping for FDA approval…
Read more »
When we recently received an email from Stand Up Paddleboard surfer Paul Zacharias, our first thought was: “Stand up paddleboard surfing? What the heck is that?” Our second thought was, “This type 1 guy is 47 years old and doin’ battle with the waves — wow!”
Turns out Paul is an accomplished athlete in this off-shoot of surfing that is quickly growing in popularity. Stand Up Paddleboard (SUP) surfing is similar to regular surfing, but…
Read more »
Since we tend to be pretty America-centric over here, we wanted to shine a spotlight on the annual conference for the European Association for the Study of Diabetes (EASD), which is Europe’s equivalent to the American Diabetes Association. EASD is a huge professional org for doctors, researchers, nurses, students, and so on, with 7,000 members — from 110 different countries!
In addition to the annual conference, the EASD also produces their own trade publication, Diabetologia,…
Read more »
